year overall survival rate ranging between 13 to 24% after simple operation, and local recurrence rate in 5 years is about 48%4. With the introduction of routine treatment methods such as radiotherapy and chemotherapy accompanying surgery for these patients, the 5 year survival rate now pegs...
of which 758 received chemotherapy while the others did not. Of all the risk factors, race, AJCC stage, grade, tumor size, AFP, fibrosis score, radiotherapy, surgery and survival time were statistically different between the
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer with a five-year survival rate of approximately 11%1. With increasing incidence, it is projected to become the second leading cause of cancer-related deaths in the United States by 20302. Current treatment options are limited. Onl...
The collected data was analyzed, descriptive statistics were generated, and the survival rate was calculated. Results: During the five-year study period, a total of 35 cases of retinoblastoma were diagnosed. The patients had an average age of 3.21 卤 1.32 years. The mos...
Outcome measures included median survival time (MST) and percentage of complete and partial response (CR+PR). Economic statistics was per capita direct medical cost (DMC) of a single cycle. TreeAge Pro Healthcare 2007 software was used to carry out cost-effectiveness and incremental cost-...
Overall survival AJCC: American Joint Committee on Cancer VOLI: Vascular or lymphatic invasion NI: Nervous invasion References Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 canc...
et al. Integrated single-cell and bulk RNA sequencing analysis identifies a neoadjuvant chemotherapy-related gene signature for predicting survival and therapy in breast cancer. BMC Med Genomics 16, 300 (2023). https://doi.org/10.1186/s12920-023-01727-0 Download citation Received12 April 2023 ...
Chemoresistance reduces the 5-year survival rate of endometrial cancer patient, which is the current major obstacle for cancer therapy. Increasing evidence state that Nrf2 contributes to chemoresistance in several kinds of cancer. However, its role in en
Recently two Phase III clinical trials have demonstrated that chemotherapy in combination with checkpoint inhibitors significantly increased pCR rate and prolonged progression-free survival in patients with triple negative breast cancers20,37. However, there was still limited understanding about the molecular...
As in 2D cell cultures, a significant reduction in cancer cell survival was also observed with the vincristine/perifosine combination in glioblastoma tumor spheroids (Supplementary Fig. S2d). Perifosine potentiates the anti-tumor efficacy of metronomic paclitaxel against lung adeno- carcinoma in ...